✓ Purity · pass✓ Lab-verifiedBatch · NovaLabsShop-provided sample
CJC/Ipamorelin Blend × novalabs.is peptides — Lab Test, July 2026
Tested · submitted by Peptigrity Team Member 01PEPTIGRITY TEAM
Filed by Peptigrity Team Member 01 ·
Sample source: shop-provided. The shop chose and sent this vial. Samples bought at retail by a member carry more weight.How we weigh evidence →
HPLC Purity
99.94%
✓ Excellent purity only
Independently confirmed on the lab’s portal✓ Extra check
COA 2607210530 matches freedomdiagnosticstesting.com's public record. So this test doesn't rest on our review alone — the lab confirms it too.
Lookup code
Andr2607210530Look it up on freedomdiagnosticstesting.com ↗Checked Jul 25, 2026
Test results
4 data points
Purity
99.94%
Endotoxins
Not tested
Heavy metals
Not tested
Stated qty
Not provided
Tested qty
Not provided
Batch / Lot
NovaLabs
COA number
2607210530
Container
White lyophilized powder
Tested by
freedomdiagnosticstesting.comView profile →
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Verification trail
| Report number | 2607210530 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 9 Sept 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | freedomdiagnosticstesting.com's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of CJC/Ipamorelin Blend from novalabs.is peptides, performed by freedomdiagnosticstesting.com on July 25, 2026. Reported purity: 99.94%. Batch NovaLabs. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Original document
Issued by freedomdiagnosticstesting.com · Jul 25, 2026 · Batch NovaLabs
♡ Likes · 0
No comments yet. Sign in to discuss this test →
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion